skip to main
|
skip to sidebar
Tuesday, September 8, 2009
Good for Mice, at the Expense of Moths
Researchers are investigating the use of
insects for preclinical testing
, which could relieve mice and other common lab animals of their traditional duties.
--Paul Thomas
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
Search This Blog
Blogs Related to QbD and Drug Development
On Pharma
QbD Viewpoint
dTC's Quality by Design Blog (Spanish)
QualityFirst from ASQ India
Ted Grasela's Pharma of the Future
Agile Clinical Development
BioIT Alliance
Chromosome
Data Mining Blog
EFPIA Blog
Emerson Global Life Sciences Blog
Life Sciences Developers and Architects
Related Content
PharmaQbD
Pharmaceutical Manufacturing
Innovative Medicines Initiative
Innovation.org (PhRMA)
ICH Home Page
About PharmaQbD Blog
Paul Thomas
Senior Editor of Pharmaceutical Manufacturing magazine, PharmaQbD.com, and PharmaManufacturing.com
View my complete profile
Subscribe To PharmaQbD Blog
Posts
Atom
Posts
Comments
Atom
Comments
Blog Archive
►
2010
(11)
►
April
(1)
►
March
(1)
►
February
(2)
►
January
(7)
▼
2009
(75)
►
December
(1)
►
November
(7)
►
October
(11)
▼
September
(10)
What's on Your QbD Calendar?
Global Outsourcing of Clinical Trials: Patient Con...
One Man's Experience: Integrating SQL*LIMS with an...
ICH Guidelines Show Their Age (and Difficulty)
FDA Initiates Study of QbD for Lyo Protein Product...
Good for Mice, at the Expense of Moths
U.S. vs. EU: Who's Better at Getting Drugs to Mark...
What is Your Favorite QbD Analytical Tool?
Drug Development, an Interactive Tour
Got QbD Education? Tell Us About It
►
August
(13)
►
July
(26)
►
June
(7)
No comments:
Post a Comment